ITRM20010465A0 - Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam - Google Patents

Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam

Info

Publication number
ITRM20010465A0
ITRM20010465A0 IT2001RM000465A ITRM20010465A ITRM20010465A0 IT RM20010465 A0 ITRM20010465 A0 IT RM20010465A0 IT 2001RM000465 A IT2001RM000465 A IT 2001RM000465A IT RM20010465 A ITRM20010465 A IT RM20010465A IT RM20010465 A0 ITRM20010465 A0 IT RM20010465A0
Authority
IT
Italy
Prior art keywords
triazolylpurines
medicam
imidazopyridine
triazolyl
adenosine
Prior art date
Application number
IT2001RM000465A
Other languages
English (en)
Inventor
Giorgio Tarzia
Giovanni Piersanti
Patrizia Minetti
Cesare Assunta Di
Grazia Gallo
Fabrizio Giorgi
Luca Giorgi
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT2001RM000465A priority Critical patent/ITRM20010465A1/it
Publication of ITRM20010465A0 publication Critical patent/ITRM20010465A0/it
Priority to KR1020047000173A priority patent/KR100884818B1/ko
Priority to PL368409A priority patent/PL217269B1/pl
Priority to PCT/IT2002/000489 priority patent/WO2003011864A1/en
Priority to JP2003517056A priority patent/JP4366186B2/ja
Priority to DE60211343T priority patent/DE60211343T2/de
Priority to ES02760555T priority patent/ES2263810T3/es
Priority to PT02760555T priority patent/PT1412354E/pt
Priority to US10/484,491 priority patent/US7230102B2/en
Priority to CA2451279A priority patent/CA2451279C/en
Priority to AU2002326146A priority patent/AU2002326146B2/en
Priority to BR0211550-6A priority patent/BR0211550A/pt
Priority to MXPA04000886A priority patent/MXPA04000886A/es
Priority to HU0401987A priority patent/HU228985B1/hu
Priority to DK02760555T priority patent/DK1412354T3/da
Priority to CNB028138481A priority patent/CN1271070C/zh
Priority to EP02760555A priority patent/EP1412354B1/en
Priority to AT02760555T priority patent/ATE325796T1/de
Publication of ITRM20010465A1 publication Critical patent/ITRM20010465A1/it
Priority to HK05100306A priority patent/HK1068334A1/xx
Priority to US11/797,566 priority patent/US7528252B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2001RM000465A 2001-07-31 2001-07-31 Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam ITRM20010465A1 (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IT2001RM000465A ITRM20010465A1 (it) 2001-07-31 2001-07-31 Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam
AT02760555T ATE325796T1 (de) 2001-07-31 2002-07-25 Derivate von triazolyl-imidazopyridine und von triazolylpurine als ligande des adenosine a2a rezeptoren und ihre verwendung als medicamente
US10/484,491 US7230102B2 (en) 2001-07-31 2002-07-25 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments
AU2002326146A AU2002326146B2 (en) 2001-07-31 2002-07-25 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments
PCT/IT2002/000489 WO2003011864A1 (en) 2001-07-31 2002-07-25 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS
JP2003517056A JP4366186B2 (ja) 2001-07-31 2002-07-25 アデノシンＡ２ａ受容体のリガンドとして有用なトリアゾリル−イミダゾピリジンおよびトリアゾリルプリンの誘導体およびその薬物としての使用
DE60211343T DE60211343T2 (de) 2001-07-31 2002-07-25 Derivate von triazolyl-imidazopyridine und von triazolylpurine als ligande des adenosine a2a rezeptoren und ihre verwendung als medicamente
ES02760555T ES2263810T3 (es) 2001-07-31 2002-07-25 Derivados de triazolil-imidazopiridina y de triazolilpurinas utiles como ligandos del receptor de adenosina a2a y su uso com medicamentos.
PT02760555T PT1412354E (pt) 2001-07-31 2002-07-25 Derivados de triazolil-imidazopiridina e de triazolilpurinas uteis como ligandos do receptor a2a da adenosina e sua utilizacao como medicamentos
KR1020047000173A KR100884818B1 (ko) 2001-07-31 2002-07-25 아데노신 Ａ２ａ 수용체의 리간드로서 유용한트리아졸릴-이미다조피리딘 및 트리아졸릴퓨린의 유도체,및 약제로서 그의 용도
CA2451279A CA2451279C (en) 2001-07-31 2002-07-25 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
PL368409A PL217269B1 (pl) 2001-07-31 2002-07-25 Pochodne triazoliloimidazopirydyny i triazolilopuryny, zawierająca je kompozycja farmaceutyczna, ich zastosowanie, sposób ich otrzymywania oraz związki pośrednie wykorzystywane w tym sposobie
BR0211550-6A BR0211550A (pt) 2001-07-31 2002-07-25 Derivados de triazolil-imidazopiridina e das triazolilpurinas úteis como ligandos do receptor a2a da adenosina, e seu uso como medicamentos
MXPA04000886A MXPA04000886A (es) 2001-07-31 2002-07-25 Derivados de triazolil-imidazopiridina y triazolilpurinas empledos como ligandos del receptor de adenosina a2a y su uso como medicamentos.
HU0401987A HU228985B1 (en) 2001-07-31 2002-07-25 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
DK02760555T DK1412354T3 (da) 2001-07-31 2002-07-25 Derivater af triazolylimidazopyridin og af triazolylpurinerne, der er egnede som ligander for adenosin A2a?-receptoren og deres anvendelse som medikamenter
CNB028138481A CN1271070C (zh) 2001-07-31 2002-07-25 用作腺苷A2α受体的配体的三唑基－咪唑并吡啶和三唑基嘌呤类的衍生物及其作为药物的应用
EP02760555A EP1412354B1 (en) 2001-07-31 2002-07-25 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS
HK05100306A HK1068334A1 (en) 2001-07-31 2005-01-13 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
US11/797,566 US7528252B2 (en) 2001-07-31 2007-05-04 Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor and their use as medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000465A ITRM20010465A1 (it) 2001-07-31 2001-07-31 Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam

Publications (2)

Publication Number Publication Date
ITRM20010465A0 true ITRM20010465A0 (it) 2001-07-31
ITRM20010465A1 ITRM20010465A1 (it) 2003-01-31

Family

ID=11455703

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001RM000465A ITRM20010465A1 (it) 2001-07-31 2001-07-31 Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam

Country Status (19)

Country Link
US (2) US7230102B2 (it)
EP (1) EP1412354B1 (it)
JP (1) JP4366186B2 (it)
KR (1) KR100884818B1 (it)
CN (1) CN1271070C (it)
AT (1) ATE325796T1 (it)
AU (1) AU2002326146B2 (it)
BR (1) BR0211550A (it)
CA (1) CA2451279C (it)
DE (1) DE60211343T2 (it)
DK (1) DK1412354T3 (it)
ES (1) ES2263810T3 (it)
HK (1) HK1068334A1 (it)
HU (1) HU228985B1 (it)
IT (1) ITRM20010465A1 (it)
MX (1) MXPA04000886A (it)
PL (1) PL217269B1 (it)
PT (1) PT1412354E (it)
WO (1) WO2003011864A1 (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770651B2 (en) * 2001-06-29 2004-08-03 Venkata Palle A2B adenosine receptor antagonists
ITRM20010465A1 (it) * 2001-07-31 2003-01-31 Sigma Tau Ind Farmaceuti Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam
AU2002357295A1 (en) * 2001-12-18 2003-06-30 Cv Therapeutics, Inc. A2a adenosine receptor antagonists
BRPI0509258A8 (pt) 2004-03-26 2019-01-22 Astrazeneca Ab composto de 8-oxoadenina 9-substituída
CA2646891A1 (en) * 2006-03-23 2007-09-27 Novartis Ag Immunopotentiating compounds
JP2009542645A (ja) 2006-07-05 2009-12-03 アストラゼネカ・アクチエボラーグ Ｔｌｒ７のモジュレーターとして作用する８−オキソアデニン誘導体
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
ATE530549T1 (de) 2007-03-19 2011-11-15 Astrazeneca Ab 9-substituierte 8-oxoadeninverbindungen als modulatoren des toll-like-receptor (tlr7)
EP2132209B8 (en) 2007-03-19 2014-04-16 AstraZeneca AB 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
PE20081887A1 (es) * 2007-03-20 2009-01-16 Dainippon Sumitomo Pharma Co Nuevo compuesto de adenina
KR101313804B1 (ko) * 2007-03-20 2013-10-01 쿠리스 인코퍼레이션 Ｈｓｐ９０ 억제제로서의 융합된 아미노 피리딘
JPWO2008114819A1 (ja) 2007-03-20 2010-07-08 大日本住友製薬株式会社 新規アデニン化合物
JP5400763B2 (ja) * 2007-05-08 2014-01-29 アストラゼネカ・アクチエボラーグ 免疫調節特性を有するイミダゾキノリン類
PE20091156A1 (es) 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
WO2009091031A1 (ja) * 2008-01-17 2009-07-23 Dainippon Sumitomo Pharma Co., Ltd. アデニン化合物の製造方法
KR20100125245A (ko) 2008-01-17 2010-11-30 다이닛본 스미토모 세이야꾸 가부시끼가이샤 아데닌 화합물의 제조 방법
TWI473614B (zh) 2008-05-29 2015-02-21 Kyowa Hakko Kirin Co Ltd Anti-analgesic inhibitors
AU2009266889B2 (en) 2008-07-03 2013-05-02 Glaxosmithkline Llc Benzimidazoles and related analogs as sirtuin modulators
KR20110040856A (ko) * 2008-07-23 2011-04-20 교와 핫꼬 기린 가부시키가이샤 편두통 치료제
WO2010106145A1 (en) 2009-03-20 2010-09-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Oxidated derivatives of triazolypurines useful as ligands of the adenosine a2a receptor and their use as medicaments
WO2012064340A1 (en) * 2009-11-13 2012-05-18 Academia Sinica Dual-action compounds targeting adenosine a2a receptor and adenosine transporter for prevention and treatment of neurodegenerative diseases
JP2013512859A (ja) * 2009-12-03 2013-04-18 大日本住友製薬株式会社 トール様受容体（ｔｌｒ）を介して作用するイミダゾキノリン
EP2657236A4 (en) * 2010-11-24 2014-02-26 Yamasa Corp NEW 2-ALKYNYL-N9-PROPARGYLADENINE AND ITS MEDICAL USE
EP2651937B8 (en) 2010-12-16 2016-07-13 Sumitomo Dainippon Pharma Co., Ltd. Imidazo[4,5-c]quinolin-1-yl derivative useful in therapy
JP5978226B2 (ja) 2010-12-17 2016-08-24 大日本住友製薬株式会社 プリン誘導体
WO2014140365A1 (en) * 2013-03-15 2014-09-18 Syngenta Participations Ag Microbicidally active imidazopyridine derivatives
CN105622495A (zh) * 2016-03-23 2016-06-01 叶芳 4-氯-3-硝基吡啶及其制备方法
GB2555264A (en) 2016-04-15 2018-04-25 Univ Oxford Innovation Ltd Adenosine receptor modulators for the treatment of circadian rhythm disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009178A1 (en) * 1989-01-31 1990-08-23 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5670501A (en) * 1994-09-01 1997-09-23 Discovery Therapeutics, Inc. N-substituted 9-alkyladenines
EP1054012B1 (en) 1998-01-05 2003-06-11 Eisai Co., Ltd. Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes
GB9915437D0 (en) * 1999-07-01 1999-09-01 Cerebrus Ltd Chemical compounds III
US6770651B2 (en) * 2001-06-29 2004-08-03 Venkata Palle A2B adenosine receptor antagonists
ITRM20010465A1 (it) 2001-07-31 2003-01-31 Sigma Tau Ind Farmaceuti Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam

Also Published As

Publication number Publication date
PT1412354E (pt) 2006-09-29
HUP0401987A3 (en) 2012-12-28
PL368409A1 (en) 2005-03-21
PL217269B1 (pl) 2014-06-30
WO2003011864A1 (en) 2003-02-13
US7528252B2 (en) 2009-05-05
ATE325796T1 (de) 2006-06-15
DK1412354T3 (da) 2006-09-18
US7230102B2 (en) 2007-06-12
HUP0401987A2 (hu) 2005-01-28
KR20040023641A (ko) 2004-03-18
CA2451279C (en) 2011-05-10
BR0211550A (pt) 2004-07-13
JP4366186B2 (ja) 2009-11-18
ES2263810T3 (es) 2006-12-16
MXPA04000886A (es) 2004-06-03
EP1412354A1 (en) 2004-04-28
HU228985B1 (en) 2013-07-29
ITRM20010465A1 (it) 2003-01-31
AU2002326146B2 (en) 2008-05-01
CN1525974A (zh) 2004-09-01
US20070249638A1 (en) 2007-10-25
EP1412354B1 (en) 2006-05-10
JP2005500355A (ja) 2005-01-06
DE60211343D1 (de) 2006-06-14
KR100884818B1 (ko) 2009-02-20
HK1068334A1 (en) 2005-04-29
US20040204428A1 (en) 2004-10-14
CA2451279A1 (en) 2003-02-13
CN1271070C (zh) 2006-08-23
DE60211343T2 (de) 2007-05-10

Similar Documents

Publication Publication Date Title
ITRM20010465A0 (it) Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam
EE04565B1 (et) Adamantaani derivaadid, nende saamine ja kasutamine
EE200300244A (et) 3-aroüülindooli derivaadid ja nende kasutamine CB2-retseptorite agonistidena
DK1283839T3 (da) Adenosin A2a-receptorantagonister
NO20020684L (no) 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler
EE201300011A (et) Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
NO20032277D0 (no) Aminotiazoler og deres anvendelse som adenosinreseptorantagonister
DE60116260D1 (de) Antivirale azaindolderivate
ATE453647T1 (de) Adenosin a2a rezeptor antagonisten
DK1453517T3 (da) Farmaceutiske formuleringer med platinderivat
AR028074A1 (es) Proceso para la preparacion de dihidroxiesteres y derivados de los mismos
EE200200607A (et) 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
DE60219196D1 (de) BICYCLISCHE Ä1,2,4ö-TRIAZOL ADENOSIN A2a REZEPTOR ANTAGONISTEN
ITMI20011057A0 (it) Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
ITMI991483A0 (it) Derivati tassanici e procedimenti per la loro preparazione
DE50114462D1 (de) Verstellbare Arbeitsbühne
ITRM20030394A1 (it) Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche.
EE200300454A (et) Bitsüklilised guanidiini derivaadid ja nende terapeutiline kasutamine
ITMI20020951A1 (it) Derivati multifunzionali del polietilenglicole loro preparazione ed impiego
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
ITMI20020872A0 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
ITMI20001053A0 (it) Derivati 2-amminotetralinici otticamente attivi, procedimenti per la loro preparazione e impiego terapeutico delle corrispondenti composizio
ITBO20020198A1 (it) Derivati 2 , 5 bis diammino 1 , 4 benzochenionici utili per il trattamento della malattia di alzheimer , metodo per la loro preparazione ed